Some advisers have criticized diversity efforts, questioned the historical contributions of people of color, and promoted debunked beliefs.

We show that, compared with surgeon predictions and existing risk-prediction tools, our machine-learning model can enhance ...

Q3 2025 Earnings Call November 13, 2025 8:30 AM ESTCompany ParticipantsJack Garman - Vice President of Investor ...

Metso has introduced a redefined OKTOP® Conditioner series aimed at boosting flotation efficiency by improving slurry preparation, reagent distr ...

Q4 2025 Earnings Call November 13, 2025 11:00 AM ESTCompany ParticipantsDan Batrack - CEO & ChairmanSteven Burdick - CFO ...

Aptose Biosciences Inc. ("Aptose" or the "Company") , a clinical-stage precision oncology company developing a tuspetinib (TUS)-based triple drug frontline therapy to treat patients with newly ...